In Vivo and In Vitro Analyses of Novel Peptidomimetic Disruptors for the Serotonin 5-HT2C Receptor Interaction With Phosphatase and Tensin Homolog

• Published in: Frontiers in pharmacology Vol. 10; p. 907
• Main Authors: Soto, Claudia A., Du, Huang-Chi, Fox, Robert G., Yang, Taegyun, Hooson, James, Anastasio, Noelle C., Gilbertson, Scott R., Cunningham, Kathryn A.
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 23.08.2019
• Subjects: drug discrimination; peptidomimetics; Pharmacology; protein phosphatase and tensin homolog; protein–protein interactions; serotonin 5-HT2C receptor
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2019.00907

Hypofunction of the serotonin (5-HT) 5-HT 2C receptor (5-HT 2C R) has been implicated in a variety of disorders including substance use disorders. As such, approaches to enhance 5-HT 2C R signaling display therapeutic potential. In the present study, we show that disruption of the 5-HT 2C R interaction with the protein phosphatase and tensin homolog (PTEN) via peptidomimetics enhances 5-HT 2C R-mediating signaling in vitro and potentiates selective 5-HT 2C R agonists in behavioral rodent models. Overall, the present study provides further evidence that 5-HT 2C R activity can be modulated through an allosteric protein–protein interaction. This work provides the groundwork for the continued exploration of protein–protein interactions that can allosterically modulate this critical receptor and other important G protein-coupled receptors (GPCRs) for new therapeutic development through mechanisms that may display clinical utility.